Compile Data Set for Download or QSAR
Report error Found 339 Enz. Inhib. hit(s) with all data for entry = 12818
TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730541(US20250122174, Example 123)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730542(US20250122174, Example 124)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730539(US20250122174, Example 121)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730540(US20250122174, Example 122)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730537(US20250122174, Example 119)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730538(US20250122174, Example 120)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730535(US20250122174, Example 117)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730536(US20250122174, Example 118)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730549(US20250122174, Example 131)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730550(US20250122174, Example 132)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730547(US20250122174, Example 129)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730548(US20250122174, Example 130)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730545(US20250122174, Example 127)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730546(US20250122174, Example 128)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730543(US20250122174, Example 125)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730544(US20250122174, Example 126)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730526(US20250122174, Example 108)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730523(US20250122174, Example 105)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730524(US20250122174, Example 106)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730521(US20250122174, Example 103)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730522(US20250122174, Example 104)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730519(US20250122174, Example 101)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730520(US20250122174, Example 102)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730533(US20250122174, Example 115)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730534(US20250122174, Example 116)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730531(US20250122174, Example 113)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730532(US20250122174, Example 114)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730529(US20250122174, Example 111)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730530(US20250122174, Example 112)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730527(US20250122174, Example 109)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730528(US20250122174, Example 110)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730573(US20250122174, Example 155)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730574(US20250122174, Example 156)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730571(US20250122174, Example 153)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730572(US20250122174, Example 154)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730569(US20250122174, Example 151)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730570(US20250122174, Example 152)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730567(US20250122174, Example 149)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730568(US20250122174, Example 150)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730581(US20250122174, Example 163)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730582(US20250122174, Example 164)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730579(US20250122174, Example 161)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730580(US20250122174, Example 162)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730577(US20250122174, Example 159)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730578(US20250122174, Example 160)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730575(US20250122174, Example 157)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730576(US20250122174, Example 158)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730557(US20250122174, Example 139)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730558(US20250122174, Example 140)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase kinase 1(Human)
Shenzhen Yuanli Shenwan Innovative Medicine

US Patent
LigandPNGBDBM730555(US20250122174, Example 137)
Affinity DataIC50: 100nMAssay Description:A stock solution of 10 mM test compound was prepared in DMSO. The compound was prepared by 5-fold and 10-point serial dilutions with HPK1 kinase assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent

Displayed 1 to 50 (of 339 total ) | Next | Last >>
Jump to: